Infamous for its genetically modified crops and monopoly-like control of the North American seed market, Monsanto is taking a rather more positive step this week with the announcement of a partnership with Danish research lab Novozymes. Monsanto will pay Novozymes $300 million up front to kickstart what the two companies are calling the BioAg Alliance, a joint venture for the discovery and development of microorganisms that can enhance plant fertility and disease resistance. Novozymes has established itself as a leader in this field of digging up bacteria, fungi, and other microbial biological agents that have a beneficial impact on crop yields, and Monsanto is already running a similar research program within its labs. This research into naturally-occurring microbes suggests a more sustainable and publicly palatable route to enhancing crop yields for Monsanto, which this year also spent $1 billion on acquiring the Climate Corporation in an effort to boost farmers productivity through a suite of localized weather prediction and advice software.
Monsanto looks to benevolent bacteria for its next breakthrough
11
Dec
2013
Comments are closed.
MONDAY, FEBRUARY 24, 2025
WHITE PAPERS
Mission-Critical Broadband – Why Governments Should Partner with Commercial Operators:
Many governments embrace mobile network operator (MNO) networks as ...
ARA at Scale: How to Choose a Solution That Grows With Your Needs:
Application release automation (ARA) tools enable best practices in...
Latest Comments
-
04. 05. 2013 00:51 -
28. 03. 2013 13:30 -
27. 03. 2013 17:21